source Post navigation Heart Protection With SGLT2, GLP-1 Drugs for Diabetes Mediated by Age – Medpage Today COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes – The Manila Times